Follow-on trial of HERACLES trial
Latest Information Update: 03 Sep 2024
At a glance
- Drugs SOF SKN (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- 03 Sep 2024 New trial record
- 19 Aug 2024 According to Noxopharm media release, while the HERACLES trial is ongoing, the company plans a seamless transition to a follow-on trial targeting the treatment of lupus patients at a number of specialist centres in Australia.